Support Cancer Treatment Fairness

BACKGROUND:
  • ASCO strongly supports requiring private health insurance plans offering intravenous (IV) cancer drug benefits to provide parity inpatient cost sharing between traditional IV drugs and oral anticancer drugs
  • Scientific advancements increasingly allow oncologists to treat cancer with oral anti-cancer medications that often provide clinical advantages over traditional forms of cancer medication
  • Some health plans impose higher cost-sharing requirements (copayments, coinsurance, etc.) on cancer patients for oral cancer drugs

Act Now! Send a Letter!

First Name

Last Name

Home Address

Email